---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-008938"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2026-01-09T23:59:59+00:00"
generated_at: "2026-05-16T11:03:18.857477+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics gets Nasdaq notice for missing annual meeting; meeting set for Jan 27, 2026

## Summary
- Received Nasdaq deficiency letter on Jan 8, 2026 for failing to hold annual meeting within 12 months of fiscal year end Dec 31, 2024.
- Company has 45 calendar days (until Feb 23, 2026) to regain compliance or submit a plan; Nasdaq may grant exception until June 29, 2026.
- Annual meeting already scheduled for Jan 27, 2026; upon holding it, compliance will be regained.

## SEC filing metadata
- accession: 0001193125-26-008938
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2026-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312526008938/0001193125-26-008938-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312526008938/d30095d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-008938
- JSON: https://secwatch.observer/filing/0001193125-26-008938.json
- Plain text: https://secwatch.observer/filing/0001193125-26-008938.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.